Kate Kalashnikova

Kate Kalashnikova

Company: Natera

Job title: Senior Translational Scientist


Clinical Evidence for ctDNA MRD – Where Are We Today and Where Are We Headed? 1:00 pm

• Overview of key clinical evidence supporting the use of ctDNA MRD in identifying patients at high risk of relapse, detecting molecular relapse or progression, and monitoring response to treatment • Top areas of research interest and future opportunities for ctDNA MRD studies, including innovative biomarker analysesRead more

day: Track 1, Day 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.